Join a Team that Lives to Improve Lives People come to Genentech from across disciplines and across the world to solve our most challenging medical conditions. You’ll find inspiration in our passion for biotechnology, our purpose to positively impact the lives of millions of patients and our dedication to our people. Joining Genentech means being part of a tradition of inquiry that will change the world. It means embracing our failures as much as our successes. It requires a willingness to look beyond the edge of what's possible. And a focus on doing the day-to-day work that makes great science happen.
The following opportunity exists in our South San Francisco, CA headquarters:
Postdoctoral Research Fellow – Preclinical and Translational Pharmacokinetics and Pharmacodynamics, Boswell Lab
We have an exciting opportunity for a highly motivated postdoctoral fellow to join the Department of Preclinical and Translational Pharmacokinetics and Pharmacodynamics at Genentech. The postdoctoral candidate will investigate structure-activity relationships governing the target independent tissue distribution of antibody therapeutics. The group utilizes a multidisciplinary approach encompassing methods such as bioconjugate chemistry, fluorescence microscopy and whole-body SPECT imaging. Projects will focus on characterizing target independent uptake of antibodies – both quantitatively at the tissue/organ level and qualitatively at the cellular and subcellular level. The individual will work independently in a team-oriented environment and collaborate with experts in imaging, protein chemistry and pharmacology to apply these findings in improving therapeutic indices for targeted drug therapies and to publish findings in top tier scientific journals. Proficiency fluorescence microscopy, conjugation chemistry and/or radiometric tissue analysis is strongly preferred.
Who You Are
Applicants must have a PhD in Biochemistry, Molecular Cell Biology, Chemical Biology, Molecular Imaging, or related discipline and a proven record of productivity in their graduate career as demonstrated by first-author publications.
Additional Recommended Qualifications:
Strong expertise in bioconjugate chemistry and/or radiochemistry
Experience with molecular (e.g. PET/SPECT) imaging
Experience with fluorescence microscopy
Experience with tissue culture, cell-based assays is a plus
Strong analytical, collaborative, communication and organizational skills
What to expect from us:
A highly functional and collaborative research environment where we aim to translate our understanding of antibody pharmacokinetics and tissue disposition to develop targeted therapies and diagnostics to transform clinical practice to benefit patient health.
Access to state-of-the-art technologies and pioneering research.
Participation in seminar series featuring academic and industry scientists.
Campus-like life style with a healthy work-life balance.
Interested applicants should send their CV, a cover letter describing your research interests and a list of 3 references.
More information about the Genentech Postdoctoral Program:
Nazarova L, Rafidi H, Mandikian D, Ferl GZ, Koerber JT, Davies CW, Ulufatu S, Ho J, Lau J, Yu SF, Ernst J, Sadowsky J and Boswell CA. “Effect of Modulating FcRn Binding on Direct and Pretargeted Tumor Uptake of Full-Length Antibodies” Mol Cancer Ther. 2020 19(4): 1052-1058.
Yip V, Palma E, Tesar DB, Mundo EE, Bumbaca D, Torres EK, Reyes NA, Shen BQ, Fielder PJ, Prabhu S, Khawli LA, and Boswell CA. “Quantitative cumulative biodistribution of antibodies in mice: Effect of modulating binding affinity to the neonatal Fc receptor”, Mabs 2014; 6(3): 689-96.
Boswell CA, Marik J, Elowson MJ, Reyes NA, Ulufatu S, Bumbaca D, Yip Y, Mundo EE, Majidy N, Van Hoy M, Goriparthi SN, Trias A, Gill HS, Williams SP, Junutula JR, Fielder PJ, Prabhu S, and Khawli LA. “Enhanced tumor retention of a radiohalogen label for site-specific modification of antibodies”, J Med Chem 2013; 56(23): 9418-9426.
Boswell CA, Tesar DB, Mukhyala K, Theil FP, Fielder PJ, and Khawli LA. “Effects of Charge on Antibody Tissue Distribution and Pharmacokinetics” (review), Bioconjugate Chemistry 2010; 21(12): 2153-2163.
Who We Are Genentech, a member of the Roche group and founder of the biotechnology industry, is dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. To solve the world's most complex health challenges, we ask bigger questions that challenge our industry and the boundaries of science to transform society. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Diversity and Inclusion (D&I) are critical to the success of our company and our impact on society. We believe that by championing diversity of background, thought and experience, we can foster a sense of belonging and provide an environment where every employee feels valued, included, and able to contribute their best for the patients we serve. We’re focused on attracting, retaining, developing and advancing our people to their full potential by rewarding bold ways of thinking and integrating inclusive behaviors into every aspect of our work.
The next step is yours. To apply today, click on the "Apply online" button.
Genentech is an equal opportunity employer & prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital & veteran status. For more information about equal employment opportunity, visit our Genentech Careers page.
At Genentech, we share salary ranges with applicants during the recruiting process, if requested. Third party salary estimates may not be accurate or up-to-date.